RKIP's role as a metastasis suppressor was initially investigated by Fu et al. [29] comparing the metastatic prostate cancer cell line (c4-2B) to the non-metastatic cell line (LNCaP). The gene discussed is PEBP1; the disease is Familial prostate cancer.